leadf
logo-loader
viewTelix Pharmaceuticals Ltd

Telix Pharmaceuticals with Proactive at the ASX Small and Mid-Cap Conference 2020

Telix Pharmaceuticals Ltd's (ASX:TLX) Christian Behrenbruch speaks with Proactive's Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020. They're a Melbourne-headquartered global biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or molecularly targeted radiation.

Quick facts: Telix Pharmaceuticals Ltd

Price: 1.69 AUD

ASX:TLX
Market: ASX
Market Cap: $429.17 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Trump Vs Biden debate: Market reaction, corporate support and future predictions

Neil Wilson from Markets.com joins Proactive London's Katie Pilbeam following the U.S. President Donald Trump and Democratic rival Joe Biden debate on Thursday night. With 47 million Americans already voted - do the markets even care? Wilson says there was 'no killer blow' which would explain...

1 day, 23 hours ago

2 min read